Skip to main content
UHS
NYSE Industrial Applications And Services

UHS Adds $700M Delayed Draw Term Loan, Bringing 2026 Liquidity Boost to $1.1B

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$149.91
Mkt Cap
$9.073B
52W Low
$140.08
52W High
$246.325
52W Position info
7.0% above low
Off High info
39% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

UHS is trading near its 52-week low of $140.08 (7.0% above the low).

Summary

UHS entered into a Twelfth Amendment to its credit agreement, adding a $700 million delayed draw term loan facility. This brings total new credit capacity in 2026 to $1.1 billion, providing substantial liquidity for general corporate purposes.


Key Events · Financing and Capital Events · UHS

  • $700M Delayed Draw Term Loan

    UHS entered into a Twelfth Amendment adding a $700 million delayed draw term loan facility, available through September 30, 2026, with a 364-day maturity from funding.

  • Liquidity Expansion

    Combined with the $400 million delayed draw term loan from April 2026, UHS has secured $1.1 billion in new credit capacity in 2026, enhancing financial flexibility.

  • Use of Proceeds

    Proceeds are for general corporate purposes, including refinancing existing indebtedness and paying related fees and expenses.

  • Lender Commitments

    Five lenders provided commitments: JPMorgan ($160M), Bank of America ($135M), Truist ($135M), U.S. Bank ($135M), and Wells Fargo ($135M).


Analysis · UHS · Industrial Applications And Services

Universal Health Services has secured a $700 million delayed draw term loan facility, lifting its total new credit capacity for 2026 to $1.1 billion. Available through September 2026, the facility matures 364 days after funding and is earmarked for general corporate purposes, including refinancing existing debt. This follows a $400 million delayed draw term loan arranged in April 2026 for the Talkspace acquisition. While the additional liquidity bolsters financial flexibility, it also raises leverage, with the new facility secured on a pari passu basis alongside existing senior secured notes. The move unfolds against a backdrop of strong Q1 earnings and a $127 million share repurchase, yet also significant legal liabilities and the termination of a key facility's Medicare/Medicaid agreement.

At the time of this filing, UHS was trading at $149.91 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $9.1B. The 52-week trading range was $140.08 to $246.33. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UHS - Latest Insights

UHS
May 21, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $164.46
Real-time Price: $149.91 info
Change: -$14.55 (-9%) info
Market Cap: $9.073B info
UHS
May 07, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $170.56
Real-time Price: $149.91 info
Change: -$20.65 (-12%) info
Market Cap: $9.073B info
UHS
Apr 28, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $182.65
Real-time Price: $149.91 info
Change: -$32.74 (-18%) info
Market Cap: $9.073B info
UHS
Apr 27, 2026, 4:26 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $186.00
Real-time Price: $149.91 info
Change: -$36.09 (-19%) info
Market Cap: $9.073B info
UHS
Apr 24, 2026, 8:23 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $175.00
Real-time Price: $149.91 info
Change: -$25.09 (-14%) info
Market Cap: $9.073B info